Wapnick Pamela (CIK 1995657) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-10). Recent activity: Sell MGX (1,911 shares), Sell MGX (2,884 shares), Buy MGX (24,000 shares), Sell MGX (1,581 shares), Sell MGX (1,576 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Metagenomi Therapeutics, Inc. (MGX) | Chief Financial Officer | Sell | 1,911 | $2,214 |
| 2026-06-10 | Metagenomi Therapeutics, Inc. (MGX) | Chief Financial Officer | Sell | 2,884 | $3,749 |
| 2026-04-03 | Metagenomi Therapeutics, Inc. (MGX) | Chief Financial Officer | Buy | 24,000 | $0 |
| 2026-03-09 | Metagenomi Therapeutics, Inc. (MGX) | Chief Financial Officer | Sell | 1,581 | $2,530 |
| 2025-12-08 | Metagenomi, Inc. (MGX) | Chief Financial Officer | Sell | 1,576 | $2,790 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | Chief Financial Officer | Sell | 1,576 | $2,853 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | Chief Financial Officer | Buy | 120,000 | $192,000 |
| 2025-06-09 | Metagenomi, Inc. (MGX) | Chief Financial Officer | Sell | 1,576 | $2,758 |
| 2025-04-03 | Metagenomi, Inc. (MGX) | Chief Financial Officer | Buy | 14,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-10